Showing results (1951-1960 of 22,015) with videos related to
Sort By:
Pageof 2,202
Oncogene|April 17, 1997
Inactivation of p53 results in high rates of homologous recombinationK L Mekeel, W Tang, L A Kachnic, et al.Oncogene|January 8, 1999
Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acidS Wu, D Zhang, Z P Zhang, et al.Oncogene|January 8, 1999
Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteinesS Chappuis-Flament, A Pasini, G De Vita, et al.Oncogene|January 8, 1999
ETS2 function is required to maintain the transformed state of human prostate cancer cellsV I Sementchenko, C W Schweinfest, T S Papas, et al.Oncogene|January 8, 1999
Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53J L Herrmann, F Briones, S Brisbay, et al.Oncogene|January 8, 1999
Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradationA Hengstermann, N J Whitaker, D Zimmer, et al.Oncogene|January 9, 1999
Promotion of early osteoclastogenesis and B lymphopoiesis in the bone marrow of transgenic rats with the env-pX gene of human T-cell lymphotropic virus type IH Yamazaki, T Kunisada, A Ishizu, et al.Oncogene|January 9, 1999
Enforced CDK4 expression in a hematopoietic cell line confers resistance to the G1 arrest induced by ionizing radiationM F Reed, V F Liu, M H Ladha, et al.Oncogene|January 9, 1999
ICER-IIgamma is a tumor suppressor that mediates the antiproliferative activity of cAMPR Razavi, J C Ramos, G Yehia, et al.Oncogene|January 9, 1999
Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancerM Tsutsumi, Y C Tsai, M L Gonzalgo, et al.Pageof 2,202